Diabetes is a condition in which the blood glucose levels in the body are extremely high. According to data provided by the American Association of Clinical Endocrinologists, more than two-thirds of people with Type 2 Diabetes have suboptimal glucose control (i.e., haemoglobin A [A1C] level > 6.5 per cent). It is known that high Hba1c levels increase the risk of short- and long-term complications. Many patients require multiple insulin injections to achieve the desired blood glucose levels. In an effort to the need for minimally invasive delivery alternative insulin injections, the i-Port injection port was developed..The i-Port is a disposable, low-profile injection port through which prescribed medications, including insulin, can be injected subcutaneously from a syringe or pen without repeated needle punctures of the skin. The i-Port is suitable for adults and children in home and health care facility environments and remains on the body while bathing, sleeping, and exercising.To support the benefit of this device, a study published in Diabetes Spectrum compared the I-Port to standard multiple dose insulin administration. Seventy four patients were randomly assigned treatment regimens i.e. standard injection (SI), a single I-port device, a dual I-port device. Fifty of the 72 participants (69.4 per cent) reported that the I-Port was useful and helpful in the management of their Diabetes. Also, the device was much more convenient than taking the SI, suggesting that researchers are a step ahead in making Diabetes a painless experience.